+971 56 274 1787WhatsApp
Symptom

Health Information

Comprehensive undefined information and treatment options at Healers Clinic Dubai.

"You are not alone in this journey."

15,000+ Patients
DHA Licensed
95% Success Rate
27+ Years
Expert Definition

Understanding This Symptom

Medical Definition

Subject Matter Expert Verified

Age-related macular degeneration (AMD) is a progressive eye disease that affects the macula, the central portion of the retina responsible for sharp, detailed vision.

It is the leading cause of irreversible vision loss in adults over 50.

AMD develops when the retinal pigment epithelium (RPE) cells deteriorate, leading to the accumulation of drusen deposits, photoreceptor death, and progressive central vision loss.

There are two forms: dry AMD (atrophic, 85-90% of cases) characterized by gradual RPE atrophy, and wet AMD (neovascular, 10-15% of cases) involving abnormal blood vessel growth beneath the retina that can cause rapid vision loss.

Quick Facts

Expert-reviewed by medical professionals
Based on current medical research
Updated for 2026 standards

Need More Information?

Our experts can provide personalized guidance

Book Consultation
Healthy State

What Optimal Health Looks Like

Understanding how your body functions when healthy helps identify dysfunction

In healthy vision, the macula functions as the retina's high-resolution center, containing the highest concentration of photoreceptor cells (cones) responsible for sharp central vision and color perception.

The retinal pigment epithelium (RPE) layer sits beneath the photoreceptors, performing critical functions: absorbing scattered light to improve image clarity, transporting nutrients from the choroidal blood supply to photoreceptors, removing metabolic waste products, regenerating visual pigment (11-cis-retinal), and maintaining the blood-retinal barrier.

The macula's fovea centralis provides 20/20 vision.

Bruch's membrane separates the RPE from the choroid, allowing nutrient exchange while blocking unwanted substances.

Healthy Function

Your body is designed to maintain balance and self-regulate

Optimal Range
Development Process

How This Develops

1

Lipofuscin accumulation - Aging RPE cells accumulate lipofuscin granules (undigested photoreceptor outer segments), impairing cellular function and creating oxidative stress

2

Drusen formation - Extracellular deposits accumulate between the RPE and Bruch's membrane, composed of lipids, proteins (complement components, amyloid-beta), and cellular debris; large, soft drusen indicate advanced disease risk

3

Oxidative stress - Reactive oxygen species (ROS) damage photoreceptors and RPE cells; mitochondrial dysfunction in RPE cells reduces ATP production and increases ROS generation

4

Chronic inflammation - Complement system dysregulation (especially CFH Y

5

Neovascularization (wet AMD) - VEGF (vascular endothelial growth factor) stimulates abnormal choroidal blood vessel growth beneath the retina; these fragile vessels leak fluid and blood, causing rapid photoreceptor death and scarring

6

Geographic atrophy (advanced dry AMD) - Progressive RPE and photoreceptor cell death creates expanding areas of retinal atrophy with irreversible vision loss

7

Impaired choroidal circulation - Reduced blood flow to the outer retina deprives photoreceptors of oxygen and nutrients

8

Matrix metalloproteinase activation - MMPs degrade extracellular matrix, compromising Bruch's membrane integrity

Understanding the mechanism helps us target the root cause rather than just treating symptoms.

Cost of Waiting

What Happens If Left Untreated

Understanding the consequences helps you make informed decisions about your health

Short-Term Consequences

Days to weeks

  • [object Object] | [object Object] | [object Object]

Time Matters

Don't wait for symptoms to worsen. Early intervention leads to better outcomes.

Common Questions

Frequently Asked Questions

Expertise Behind This Guide

Evidence-Based Information

Dr. Hafeel Afsar, DHA Licensed Integrative Medicine Specialization: Functional ophthalmology support, age-related degenerative conditions, nutritional medicine Qualifications: Board-certified in Integrative Medicine, Advanced Training in Nutritional Ophthalmology Experience: 15+ years managing complex chronic conditions with integrative approaches including AMD prevention and support protocols

References & Further Reading

Age-Related Eye Disease Study 2 Research Group. Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration: The AREDS2 Randomized Clinical Trial. JAMA. 2013;309(19):2005-2015. doi:10.1001/jama.2013.4997 - Landmark trial establishing AREDS2 formula efficacy.
Wong WL, Su X, Li X, et al. Global Prevalence of Age-Related Macular Degeneration and Disease Burden Projection for 2020 and 2040: A Systematic Review and Meta-Analysis. Lancet Glob Health. 2014;2(2):e106-e116. doi:10.1016/S2214-109X(13)70145-1 - Comprehensive global epidemiology of AMD.
Fleckenstein M, Keenan TDL, Guymer RH, et al. Age-Related Macular Degeneration. Nat Rev Dis Primers. 2021;7(1):31. doi:10.1038/s41572-021-00270-3 - Comprehensive review of AMD pathophysiology, diagnosis, and treatment.
Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for Neovascular Age-Related Macular Degeneration. N Engl J Med. 2006;355(14):1419-1431. doi:10.1056/NEJMoa054481 - Landmark trial establishing anti-VEGF therapy for wet AMD.
Chew EY, Clemons TE, Agrón E, et al. Long-Term Outcomes of Adding Lutein/Zeaxanthin and Omega-3 Fatty Acids to the AREDS Supplementation on Progression to Late Age-Related Macular Degeneration: The AREDS2 Report 28. JAMA Ophthalmol. 2023;141(8):731-739. doi:10.1001/jamaophthalmol.2023.2224 - Long-term follow-up of AREDS2 supplementation benefits.
Heier JS, Lad EM, Holz FG, et al. Pegcetacoplan for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration: 18-Month Results from the DERBY and OAKS Trials. Ophthalmology. 2023;130(7):710-724. doi:10.1016/j.ophtha.2023.02.011 - Evidence for complement inhibition in geographic atrophy.
Seddon JM, Reynolds R, Maller J, et al. Prediction Model for Prevalence and Incidence of Advanced Age-Related Macular Degeneration Based on Genetic, Demographic, and Environmental Variables. Invest Ophthalmol Vis Sci. 2009;50(5):2044-2053. doi:10.1167/iovs.08-3064 - Risk prediction model incorporating genetic and environmental factors.

This information is for educational purposes and not a substitute for professional medical advice.